
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
A ZipChip CZE system coupled to Bruker maXis II UHR-QTOF affords deep profiling of charge variants of highly heterogeneous mAbs such as cetuximab





